{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:31:55Z","timestamp":1793716315792,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05748-1","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:51:54Z","timestamp":1786931514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cholinesterase inhibitors and sexual disinhibition in dementia: a FAERS disproportionality study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2270-9370","authenticated-orcid":false,"given":"Kaofei","family":"Sayion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"3","key":"5748_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-150034","volume":"46","author":"RM Ahmed","year":"2015","unstructured":"Ahmed RM et al (2015) Characterizing sexual behavior in frontotemporal dementia. J Alzheimers Dis 46(3):677\u2013686. https:\/\/doi.org\/10.3233\/JAD-150034","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"5748_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/bcp.15178","volume":"89","author":"W Alkabbani","year":"2023","unstructured":"Alkabbani W et al (2023) Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of sodium-glucose cotransporter-2 inhibitors. Br J Clin Pharmacol 89(2):431\u2013439. https:\/\/doi.org\/10.1111\/bcp.15178","journal-title":"Br J Clin Pharmacol"},{"key":"5748_CR3","doi-asserted-by":"publisher","unstructured":"Bai W, Douros A, Gravel CA (2025) Masking in active comparator designs in pharmacovigilance: a retrospective bias analysis on the spontaneous reporting of thiazolidinediones and cardiovascular events. Pharmacoepidemiol Drug Saf 34(1):e70102. https:\/\/doi.org\/10.1002\/pds.70102","DOI":"10.1002\/pds.70102"},{"issue":"1","key":"5748_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"4","key":"5748_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/08919887231225481","volume":"37","author":"SQ Borges","year":"2024","unstructured":"Borges SQ, Camargos EF (2024) Prevalence of and factors associated with hypersexuality in patients with dementia. J Geriatr Psychiatry Neurol 37(4):263\u2013271. https:\/\/doi.org\/10.1177\/08919887231225481","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"5748_CR6","doi-asserted-by":"publisher","unstructured":"Chapman KR, Spitznagel MB (2019) Measurement of sexual disinhibition in dementia: a systematic review. Int J Geriatr Psychiatry 34(12):1747\u20131757. https:\/\/doi.org\/10.1002\/gps.5208","DOI":"10.1002\/gps.5208"},{"issue":"7","key":"5748_CR7","first-page":"78","volume":"10","author":"ZN Chemali","year":"2003","unstructured":"Chemali ZN (2003) Donepezil and hypersexuality: a report of two cases. Primary Psychiatry 10(7):78\u201379","journal-title":"Primary Psychiatry"},{"key":"5748_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2024","unstructured":"Cutroneo PM, Sartori D, Tuccori M et al (2024) Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul 3:1323057. https:\/\/doi.org\/10.3389\/fdsfr.2023.1323057","journal-title":"Front Drug Saf Regul"},{"key":"5748_CR9","doi-asserted-by":"publisher","unstructured":"de Boissieu P, Kanagaratnam L, Abou Taam M, Roux MP, Dram\u00e9 M, Trenque T (2014) Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database. Pharmacoepidemiol Drug Saf 23(9):989\u2013992. https:\/\/doi.org\/10.1002\/pds.3622","DOI":"10.1002\/pds.3622"},{"key":"5748_CR10","doi-asserted-by":"publisher","unstructured":"Floody OR (2014) Role of acetylcholine in control of sexual behavior of male and female mammals. Pharmacol Biochem Behav 120:50\u201356. https:\/\/doi.org\/10.1016\/j.pbb.2014.02.007","DOI":"10.1016\/j.pbb.2014.02.007"},{"key":"5748_CR11","doi-asserted-by":"publisher","unstructured":"Fox C, et al (2012) Efficacy of memantine for agitation in Alzheimer\u2019s dementia: a randomised double-blind placebo controlled trial. PLoS One\u00a07(5):e35185. https:\/\/doi.org\/10.1371\/journal.pone.0035185","DOI":"10.1371\/journal.pone.0035185"},{"key":"5748_CR12","doi-asserted-by":"publisher","unstructured":"Fusaroli M et al (2024) The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): development and statement. Drug Saf 47(6):575\u2013584. https:\/\/doi.org\/10.1007\/s40264-024-01421-9","DOI":"10.1007\/s40264-024-01421-9"},{"key":"5748_CR13","doi-asserted-by":"publisher","unstructured":"Grant JE, et al (2010) Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl) 212(4):603\u2013612.\u00a0https:\/\/doi.org\/10.1007\/s00213-010-1994-5","DOI":"10.1007\/s00213-010-1994-5"},{"issue":"9","key":"5748_CR14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1111\/bcp.15802","volume":"89","author":"CA Gravel","year":"2023","unstructured":"Gravel CA et al (2023) Considerations on the use of different comparators in pharmacovigilance: a methodological review. Br J Clin Pharmacol 89(9):2671\u20132676. https:\/\/doi.org\/10.1111\/bcp.15802","journal-title":"Br J Clin Pharmacol"},{"key":"5748_CR15","doi-asserted-by":"publisher","unstructured":"Green GH, Diggle PJ (2007) On the operational characteristics of the Benjamini and Hochberg false discovery rate procedure. Stat Appl Genet Mol Biol. 6(1):Article 27. https:\/\/doi.org\/10.2202\/1544-6115.1302\u00a0","DOI":"10.2202\/1544-6115.1302"},{"key":"5748_CR16","doi-asserted-by":"publisher","unstructured":"Haghani Tehrani P, Kohli KK, Khafaja MH (2021) Donepezil and inappropriate sexual behavior in a patient with vascular dementia and on bupropion: a case report. J Clin Psychopharmacol 41(6):696\u2013698. https:\/\/doi.org\/10.1097\/JCP.0000000000001458","DOI":"10.1097\/JCP.0000000000001458"},{"key":"5748_CR17","doi-asserted-by":"publisher","unstructured":"Haldane JBS (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20(4):309\u2013311. https:\/\/doi.org\/10.1111\/j.1469-1809.1955.tb01285.x","DOI":"10.1111\/j.1469-1809.1955.tb01285.x"},{"key":"5748_CR18","doi-asserted-by":"publisher","unstructured":"Kishi T et al (2017) The effects of memantine on behavioral disturbances in patients with Alzheimer\u2019s disease: a meta-analysis. Neuropsychiatr Dis Treat 13:1909\u20131928. https:\/\/doi.org\/10.2147\/NDT.S142839","DOI":"10.2147\/NDT.S142839"},{"key":"5748_CR19","doi-asserted-by":"publisher","unstructured":"Liang YQ, Tang XC (2006) Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats. Acta Pharmacol Sin 27(9):1127\u20131136.\u00a0https:\/\/doi.org\/10.1111\/j.1745-7254.2006.00411.x","DOI":"10.1111\/j.1745-7254.2006.00411.x"},{"key":"5748_CR20","doi-asserted-by":"publisher","unstructured":"Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5(2):160\u2013170. https:\/\/doi.org\/10.1038\/nrd1958","DOI":"10.1038\/nrd1958"},{"key":"5748_CR21","doi-asserted-by":"publisher","unstructured":"Lo Coco D, Cannizzaro E (2010) Inappropriate sexual behaviors associated with donepezil treatment: a case report. J Clin Psychopharmacol 30(2):221\u2013222.\u00a0https:\/\/doi.org\/10.1097\/JCP.0b013e3181d35c14","DOI":"10.1097\/JCP.0b013e3181d35c14"},{"issue":"4","key":"5748_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jppr.1185","volume":"46","author":"E Luong","year":"2016","unstructured":"Luong E et al (2016) Donepezil: a case of inappropriate sexual behaviours in dementia. J Pharm Pract Res 46(4):342\u2013345. https:\/\/doi.org\/10.1002\/jppr.1185","journal-title":"J Pharm Pract Res"},{"key":"5748_CR23","doi-asserted-by":"publisher","unstructured":"Mendez MF, Shapira JS (2013) Hypersexual behavior in frontotemporal dementia: a comparison with early-onset Alzheimer\u2019s disease. Arch Sex Behav 42(3):501\u2013509. https:\/\/doi.org\/10.1007\/s10508-012-0042-4","DOI":"10.1007\/s10508-012-0042-4"},{"key":"5748_CR24","doi-asserted-by":"publisher","unstructured":"Moore TJ, Glenmullen J, Mattison DR (2014) Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 174(12):1930\u20131933. https:\/\/doi.org\/10.1001\/jamainternmed.2014.5262","DOI":"10.1001\/jamainternmed.2014.5262"},{"key":"5748_CR25","doi-asserted-by":"publisher","unstructured":"Pariente A, Gregoire F, Fourrier-R\u00e9glat A, Haramburu F, Moore N (2007) Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf 30(10):891\u2013898. https:\/\/doi.org\/10.2165\/00002018-200730100-00007","DOI":"10.2165\/00002018-200730100-00007"},{"key":"5748_CR26","doi-asserted-by":"publisher","unstructured":"Potter AS, Bucci DJ, Newhouse PA (2012) Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology 220(2):331\u2013340. https:\/\/doi.org\/10.1007\/s00213-011-2476-0","DOI":"10.1007\/s00213-011-2476-0"},{"issue":"3","key":"5748_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0018578719882323","volume":"56","author":"N Reddy","year":"2021","unstructured":"Reddy N et al (2021) Existence of notoriety bias in the FDA Adverse Event Reporting System database. Hosp Pharm 56(3):152\u2013158. https:\/\/doi.org\/10.1177\/0018578719882323","journal-title":"Hosp Pharm"},{"issue":"14","key":"5748_CR28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B et al (2003) Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 348(14):1333\u20131341. https:\/\/doi.org\/10.1056\/NEJMoa013128","journal-title":"N Engl J Med"},{"key":"5748_CR29","doi-asserted-by":"publisher","unstructured":"Segrec N, Zaman R, Pregelj P (2016) Increased libido associated with donepezil treatment: a case report. Psychogeriatrics 16(1):70\u201372. https:\/\/doi.org\/10.1111\/psyg.12113","DOI":"10.1111\/psyg.12113"},{"key":"5748_CR30","doi-asserted-by":"publisher","unstructured":"Trillenberg P, Sprenger A, Machner B (2023) Sensitivity and specificity in signal detection with the reporting odds ratio and the information component. Pharmacoepidemiol Drug Saf 32(8):910\u2013917. https:\/\/doi.org\/10.1002\/pds.5624","DOI":"10.1002\/pds.5624"},{"key":"5748_CR31","doi-asserted-by":"publisher","unstructured":"Yang Y et al (2024) Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) data from 2004 to 2023. Front Pharmacol 15:1439115. https:\/\/doi.org\/10.3389\/fphar.2024.1439115","DOI":"10.3389\/fphar.2024.1439115"},{"key":"5748_CR32","doi-asserted-by":"publisher","unstructured":"Zhang N et al (2024) Cholinesterase inhibitors-associated torsade de pointes \/ QT prolongation: a real-world pharmacovigilance study based on the FAERS database. Front Pharmacol 14:1343650. https:\/\/doi.org\/10.3389\/fphar.2023.1343650","DOI":"10.3389\/fphar.2023.1343650"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05748-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05748-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05748-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:51:59Z","timestamp":1786931519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05748-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":32,"alternative-id":["5748"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05748-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FAERS releases only secondary, fully anonymized case data with no identifiers; because no identifiable person is involved and the work falls outside human-subjects research, institutional review board approval was not required. This determination is provided as an author self-declaration of exemption, and no hospital IRB letter was obtained.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable: the analysis draws only on anonymized, openly released FAERS records, so participant consent does not arise.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study contains no individual person\u2019s identifiable data, images, or details.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a post-hoc, exploratory pharmacovigilance signal-detection analysis, and the study was not pre-registered. All analytical parameters, endpoints, and thresholds are disclosed in full in the main text and the\n                      \n                      in the interest of transparency.","order":4,"name":"Ethics","label":"Protocol registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author conceived the study, designed and performed the analysis, interpreted the statistical results, and wrote the initial draft and core argument of this work; the scientific content, study perspective, arguments, and conclusions are the author\u2019s own. Generative artificial intelligence tools (large language model-based assistants) were used for literature collation, developing the author\u2019s initial draft into the formal manuscript text, Chinese-to-English translation, language polishing, and drafting of analysis code. All model-assisted content\u2014including the bibliographic details of cited references, numerical values, and statements of conclusions\u2014was checked and corrected by the author item by item; responsibility for the data analysis, statistical computation, interpretation of results, and the final scholarly claims rests entirely with the author. Generative artificial intelligence was not used to generate or alter any raw data or analytical results.","order":5,"name":"Ethics","label":"Generative-AI use disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}